查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1961320

正子断层扫描市场－全球产业规模、份额、趋势、机会、预测：按产品类型、应用、最终用户、地区和竞争对手划分，2021-2031年

Positron Emission Tomography Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球正子断层扫描（PET）市场预计将从 2025 年的 31.2 亿美元成长到 2031 年的 46.8 亿美元，复合年增长率为 6.99%。

正子断层扫描（PET）是一种利用放射性示踪剂测量代谢过程的功能性影像技术，能够对复杂的病理状况进行精确诊断和后续观察。市场成长的主要驱动力是慢性病（尤其是肿瘤和心臟病）发病率的上升，这推动了对高精度早期检测工具的需求。此外，PET/CT和PET/MRI等混合系统的日益普及提高了诊断准确性和工作流程效率，加速了该技术在全球范围内的推广应用。

市场概览
预测期 2027-2031
市场规模：2025年 31.2亿美元
市场规模：2031年 46.8亿美元
复合年增长率：2026-2031年 6.99%
成长最快的细分市场 肿瘤学
最大的市场 北美洲

另一方面，复杂的物流和医用放射性同位素的间歇性短缺对市场扩张构成重大障碍，并导致供应链脆弱。这些对时间要求极高的物质的生产依赖于数量有限的核子反应炉，也成为稳定提供服务的瓶颈。世界核能协会在2024年发布的报告凸显了该领域的巨大规模和这些诊断方法的关键作用，报告显示，全球约有5000万例核医学检查，证实了现代医学依赖这些先进技术。

市场驱动因素

全球癌症负担日益加重是正子断层扫描（PET）市场扩张的主要驱动力。癌症病例的增加提高了对精准分期、重新评估和疗效评估的需求，直接导致PET扫描次数的增加。这些扫描对于检测先于解剖结构变化的代谢变化至关重要，从而能够进行适当的治疗性介入。美国癌症协会发布的《2024年癌症事实与数据》报告也印证了这一增长趋势，该报告预测仅在美国每年就将新增2,001,140例癌症病例，确保了整个治疗过程中对影像服务持续的需求。

同时，用于治疗神经系统疾病（尤其是阿兹海默症）的新型放射性示踪剂的研发，是推动二级市场成长的强劲动力。放射性药物的创新使得淀粉样斑块和Tau蛋白纤维的可视化成为可能，从而拓展了PET在老年医学和神经病学领域的效用，以应对失智症障碍。根据阿兹海默症协会2024年3月发布的报告，约有690万65岁及以上的美国人患有老年痴呆症症，这是一个庞大的患者群体。这些药物的商业性成功也体现在Lantheus公司2023年全年13亿美元的全球销售额上，反映出先进显影剂的强劲市场接受度。

市场挑战

复杂的物流系统和医用放射性同位素的间歇性供不应求是全球正子断层扫描（PET）市场发展的主要障碍。该行业依赖脆弱的供应链，关键示踪剂的生产集中在有限的设施和老旧的核子反应炉中。一旦这些关键基础设施面临意外维护或停机，就会立即出现瓶颈，扰乱全球医疗保健系统。因此，医疗机构难以维持稳定的工作安排，导致检查取消，并且除非能够保证可靠的示踪剂供应，否则不愿投资新的PET设备。

由于这些快速崩坏的材料需要即时供应，有效储备受到阻碍，这种脆弱性进一步加剧。供应不稳定会削弱市场信心，阻碍营运能力，并妨碍诊断能力的充分利用。正如《欧洲核子医学》杂誌在2024年指出的那样，欧洲市场占全球诊断同位素消耗量的20%以上，凸显了大量患者极易受到生产网路中断的影响。这种供应不稳定将限制先进检测方法的应用，并最终减缓整体市场成长。

市场趋势

将人工智慧 (AI) 整合到影像重建中，从根本上改变了 PET 系统的功能。製造商正在利用深度学习演算法来提高信噪比，从而在减少放射性示踪剂用量和缩短扫描时间的同时，实现高品质成像。这项技术变革平衡了影像清晰度和病患辐射暴露，使得检测以前无法发现的病灶成为可能。美国食品药物管理局(FDA) 在 2024 年 8 月发布的报告也印证了这一趋势：在已通过核准的AI/机器学习医疗设备中，79% 为放射科设备，凸显了这些软体增强功能获得了重要的监管核准。

同时，用于治疗和诊断的放射性药物的成长正在促成诊断性PET成像与标靶治疗之间的直接商业性合作。这种方法将基于诊断性同位素和基因组标靶的治疗药物相结合，需要在治疗前进行PET扫描以确认标靶表达。这确保了只有预期获益的患者才能接受治疗，并将扫描确立为高价值疗法的先决条件。根据诺华公司截至2024年7月的财年财务报告，其放射性配体疗法「Pluvicto」的销售额达到3.45亿美元（经外汇调整后增长44%），这必然导致对PSMA-PET成像的需求增加。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球正子断层扫描市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 产品类型（全环PET扫描器、部分环PET扫描器）
    • 依应用领域（肿瘤科、心臟科、神经科等）
    • 依最终使用者（医院、诊断中心、研究机构等）划分
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美正子断层扫描市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲正子断层扫描市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区正子断层扫描市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲正子断层扫描市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲正子断层扫描市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球正子断层扫描市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • GE HealthCare Technologies Inc.
  • Toshiba Corporation
  • Koninklijke Philips NV
  • Siemens Healthineers AG
  • Hitachi Medical Corporation
  • Positron Corporation
  • Mediso Ltd.
  • Yangzhou Kindsway Biotech Co., Ltd.

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 23761

The Global Positron Emission Tomography Market is projected to expand from USD 3.12 Billion in 2025 to USD 4.68 Billion by 2031, registering a CAGR of 6.99%. As a functional imaging modality using radiotracers to measure metabolic processes, PET enables the precise diagnosis and monitoring of complex medical conditions. Market growth is primarily driven by the rising prevalence of chronic diseases, especially within oncology and cardiology, creating a need for high-precision early detection tools. Furthermore, the increasing adoption of hybrid systems like PET/CT and PET/MRI is enhancing diagnostic accuracy and workflow efficiency, boosting technology uptake globally.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.12 Billion
Market Size 2031USD 4.68 Billion
CAGR 2026-20316.99%
Fastest Growing SegmentOncology
Largest MarketNorth America

Conversely, market expansion faces significant hurdles due to complex logistics and sporadic shortages of medical radioisotopes, which cause supply chain vulnerabilities. The dependence on a limited number of production reactors for these time-sensitive materials creates bottlenecks for consistent service delivery. Highlighting the sector's vast scale and the critical role of these diagnostics, the World Nuclear Association reported in 2024 that approximately 50 million nuclear medicine procedures were performed globally, underscoring modern healthcare's reliance on these advanced capabilities.

Market Driver

The rising global burden of cancer acts as the primary catalyst expanding the Positron Emission Tomography landscape. Increasing oncological cases necessitate precise staging, restaging, and treatment response evaluation, directly boosting PET scan volumes. These procedures are vital for detecting metabolic changes prior to anatomical alterations, facilitating appropriate therapeutic interventions. Emphasizing this growing burden, the American Cancer Society's 'Cancer Facts & Figures 2024' report projected 2,001,140 new cancer cases in the United States alone for the year, ensuring sustained demand for imaging services throughout the care continuum.

Concurrently, the development of novel radiotracers for neurological conditions, specifically Alzheimer's disease, is a strong secondary market driver. Innovations in radiopharmaceuticals allow for the visualization of amyloid plaques and tau tangles, extending PET utility to geriatric and neurology sectors to address cognitive disorders. According to the Alzheimer's Association's March 2024 report, an estimated 6.9 million Americans aged 65 and older are living with Alzheimer's dementia, representing a significant patient base. The commercial success of these agents is illustrated by Lantheus, which reported worldwide revenue of $1.3 billion for the full year 2023, reflecting strong financial adoption of advanced imaging agents.

Market Challenge

The complex logistics and intermittent shortages of medical radioisotopes represent a significant barrier to the Global Positron Emission Tomography Market. The sector depends on a fragile supply chain where essential tracer production is concentrated in limited facilities and aging nuclear reactors. When these key infrastructure points experience unplanned maintenance or shutdowns, it causes immediate bottlenecks that disrupt the global healthcare system. Consequently, facilities struggle to maintain consistent schedules, leading to cancellations and hesitation to invest in new PET modalities without assured tracer availability.

This vulnerability is worsened by the just-in-time nature of these rapidly decaying materials, which prevents effective stockpiling. The lack of a stable supply undermines market confidence and hampers operational throughput, preventing full utilization of diagnostic capabilities. As noted by Nuclear Medicine Europe in 2024, the European market accounted for over 20% of global diagnostic isotope consumption, highlighting the massive volume of patients vulnerable to production network disruptions. Such supply insecurity restricts the broader adoption of advanced procedures, ultimately slowing the market's overall growth.

Market Trends

Artificial intelligence integration in image reconstruction is fundamentally transforming PET system capabilities. Manufacturers are utilizing deep learning algorithms to improve signal-to-noise ratios, facilitating high-quality imaging with reduced radiotracer doses and shorter scan times. This technological shift balances image clarity with patient exposure, enabling the detection of previously invisible lesions. Validating this trend, the U.S. Food and Drug Administration reported in August 2024 that radiology devices comprised 79% of all authorized AI/ML-enabled medical devices, highlighting the significant regulatory clearance of these software enhancements.

Simultaneously, the growth of theranostic radiopharmaceuticals is creating a direct commercial link between diagnostic PET imaging and targeted therapy. This method pairs a diagnostic isotope with a therapeutic agent based on genomic targets, requiring a PET scan to confirm target expression before treatment. This ensures therapy is reserved for patients who will benefit, making the scan a prerequisite for high-value treatments. According to Novartis' July 2024 financial report, sales for the radioligand therapy Pluvicto reached $345 million, a 44% increase in constant currency, driving requisite demand for companion PSMA-PET imaging.

Key Market Players

  • GE HealthCare Technologies Inc.
  • Toshiba Corporation
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG
  • Hitachi Medical Corporation
  • Positron Corporation
  • Mediso Ltd.
  • Yangzhou Kindsway Biotech Co., Ltd.

Report Scope

In this report, the Global Positron Emission Tomography Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Positron Emission Tomography Market, By Product Type

  • Full Ring PET Scanner
  • Partial Ring PET Scanner

Positron Emission Tomography Market, By Application

  • Oncology
  • Cardiology
  • Neurology
  • Others

Positron Emission Tomography Market, By End User

  • Hospitals
  • Diagnostic Centres
  • Research Institutes
  • others

Positron Emission Tomography Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Positron Emission Tomography Market.

Available Customizations:

Global Positron Emission Tomography Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Positron Emission Tomography Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Full Ring PET Scanner, Partial Ring PET Scanner)
    • 5.2.2. By Application (Oncology, Cardiology, Neurology, Others)
    • 5.2.3. By End User (Hospitals, Diagnostic Centres, Research Institutes, others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Positron Emission Tomography Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Positron Emission Tomography Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Positron Emission Tomography Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Positron Emission Tomography Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Positron Emission Tomography Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Positron Emission Tomography Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Positron Emission Tomography Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Positron Emission Tomography Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Positron Emission Tomography Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Positron Emission Tomography Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Positron Emission Tomography Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Positron Emission Tomography Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Positron Emission Tomography Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Positron Emission Tomography Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Positron Emission Tomography Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Positron Emission Tomography Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Positron Emission Tomography Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Positron Emission Tomography Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Positron Emission Tomography Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Positron Emission Tomography Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Positron Emission Tomography Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Positron Emission Tomography Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Positron Emission Tomography Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Positron Emission Tomography Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Positron Emission Tomography Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. GE HealthCare Technologies Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Toshiba Corporation
  • 15.3. Koninklijke Philips N.V.
  • 15.4. Siemens Healthineers AG
  • 15.5. Hitachi Medical Corporation
  • 15.6. Positron Corporation
  • 15.7. Mediso Ltd.
  • 15.8. Yangzhou Kindsway Biotech Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer